Boston dental AI startup Overjet has raised $42.5 million in venture capital financing, an investment round that comes just months after its first funding and news of an FDA clearance.
The company’s Dental Assist, which was the first-ever dental AI product to get FDA approval earlier this year, encodes disease identification and progression into software, helping dentists deliver patient care and insurers operate more accurately and efficiently.
The oversubscribed Series B round was led by General Catalyst and Insight Partners with participation from existing investors Crosslink Capital and the MIT-affiliated E14 Fund.
“Overjet's cutting-edge software has seen incredible demand from clinicians and insurers alike, who see our dental AI as a transformational technology to advance patient oral healthcare," said the company’s CEO and co-founder Wardah Inam in a statement. "The new financing will accelerate our next chapter of growth to support our customers, grow the team, and invest in the next generation of technology to support patient care."
The company is working on selling its product to large and small dental offices as well as insurers, with 16 major carriers already counted as customers.
Inam, a Harvard and MIT graduate, founded the company in 2018 along with Alexander Jelicich, a fellow alum of both schools and dental expert.
Overjet has grown to more than 60 employees this year, and the company said it expects to double headcount in the next 6 months. It’s headquartered in Boston but has switched to remote-first operations to try to attract talent.
The latest funding round, on top of a $27 million Series A in August, brings the company’s total financing to $80 million and its valuation to $425 million.
